Release Date: 03/08/20 09:06 Summary: June 2020 Quarterly Activities Report & Appendix 4C Price Sensitive: Yes Download Document 717.98KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%